文献速递烧伤创面修复

美国中心自体皮肤细胞悬液治疗小面积烧伤的真实世界住院时间与费用分析

Analysis of real-world length of stay data and costs associated with use of autologous skin cell suspension for the treatment of small burns in U.S. centers.
PubMed 文献 · Burns · 2022-12-05

基于美国500家医疗机构2019年1月至2020年8月的电子病历数据,将151例接受自体皮肤细胞悬液(ASCS)±断层皮片移植(STSG)的小面积烧伤(体表面积<20%)成人患者与2243例STSG患者匹配(63对)。ASCS±STSG组住院时间18.5天,STSG组20.6天(差值2.1天,10.2%),每例ASCS±STSG患者床位费用节省15587.62美元,总费用节省22268.03美元。真实世界数据支持BEACON模型预测。

要点

  • 小面积烧伤用ASCS±STSG较单用STSG住院时间缩短2.1天(18.5天 vs 20.6天)。
  • 每例ASCS±STSG患者床位费用节省15587.62美元,总费用节省22268.03美元。
  • 真实世界数据与BEACON模型预测一致,支持ASCS±STSG缩短住院和节省费用。

核心结论

  • 真实世界数据分析显示,小面积烧伤采用ASCS±STSG治疗较STSG缩短住院时间并大幅节省费用,支持BEACON模型预测的有效性。

研究设计与样本

  • 收集2019年1月至2020年8月美国500家医疗机构电子病历数据,识别接受ASCS±STSG住院治疗的小面积烧伤成人患者,并按基线特征与STSG患者匹配。
  • 共识别151例ASCS±STSG和2243例STSG病例,匹配63对;男性占63.0%,平均年龄44.2岁。
  • 假设住院费用为每天7554美元,占总体费用的70%,计算两队列平均住院时间和费用。

主要发现

  • ASCS±STSG组住院时间18.5天,STSG组20.6天,差值2.1天(10.2%)。
  • 该差异使每例ASCS±STSG患者床位费用节省15587.62美元。
  • ASCS±STSG每例患者总费用节省22268.03美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autologous skin cell suspension (ASCS) is a treatment for acute thermal burn injuries associated with significantly lower donor skin requirements than conventional split-thickness skin grafts (STSG). Projections using the BEACON model suggest that among patients with small burns (total body surface area [TBSA]<20 %), use of ASCS± STSG leads to a shorter length of stay (LOS) in hospital and cost savings compared with use of STSG alone. This study evaluated whether data from real-world clinical practice corroborate these findings. MATERIALS AND METHODS: Electronic medical record data were collected from January 2019 through August 2020 from 500 healthcare facilities in the United States. Adult patients receiving inpatient treatment with ASCS± STSG for small burns were identified and matched to patients receiving STSG using baseline characteristics. LOS was assumed to cost $7554/day and to account for 70 % of overall costs. Mean LOS and costs were calculated for the ASCS± STSG and STSG cohorts. RESULTS: A total of 151 ASCS± STSG and 2243 STSG cases were identified; 63.0 % of patients were male and the average age was 44.2 years. Sixty-three matches were made between cohorts. LOS was 18.5 days with ASCS± STSG and 20.6 days with STSG (difference: 2.1 days [10.2 %]). This difference led to bed cost savings of $15,587.62 per ASCS± STSG patient. Overall cost savings with ASCS± STSG were $22,268.03 per patient. CONCLUSIONS: Analysis of real-world data shows that treatment of small burn injuries with ASCS± STSG provides reduced LOS and substantial cost savings compared with STSG, supporting the validity of the BEACON model projections.

来源:Burns,查看原文。版权归原作者所有。

引用

  1. Carson JS, Carter JE, Hickerson WL, et al. Analysis of real-world length of stay data and costs associated with use of autologous skin cell suspension for the treatment of small burns in U.S. centers. Burns. 2022. PMID: 36813602. doi:10.1016/j.burns.2022.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。